HealthNotableCorroboratingDeveloping
10.0
Semaglutide debate in South Africa highlights systemic public trust deficit in healthcare institutions
Mail & GuardianLO·ZA·3 days ago
HealthSingle-sourceMedium
5.3
NHS England approves Fampridine for multiple sclerosis mobility treatment
NHS England has authorized the use of Fampridine to improve walking ability in patients with multiple sclerosis. The drug functions by enhancing nerve signal conduction, with approximately 5,000 patients currently eligible for the treatment.
Score Breakdown
Mosaic Score5.3
Confidence0.9
Significance0.5
Source credibility0.3
Intelligence Tags
Locations
England
Entities
country
Related signals
8 foundHealthSingle-source
2.1
Hospital José Carrasco Arteaga secures one-year supply of multiple sclerosis medication
El UniversoLO·EC · NG·2 days ago
HealthDisputed
1.9
Analysis challenges national security framing of US pharmaceutical supply chain vulnerabilities
STAT NewsLO·US · CN·2 days ago
HealthNotableConfirmedDeveloping
10.0
Argentine Pharmacists Oppose Deregulation of Over-the-Counter Drug Sales
PerfilLO·AR·2 days ago
HealthNotableConfirmedDeveloping
10.0
FDA issues recall for cetirizine batches over cross-contamination risk
La República (Peru)LO·US·3 days ago
TradeNotableConfirmedDeveloping
10.0
Austria initiates pharmaceutical industrial policy in response to proposed US tariff threats
Die PresseLO·AT · US·3 days ago
MarketsNotableConfirmedDeveloping
10.0
Mercado Livre seeks regulatory changes to launch pharmacy operations in Chile
Valor Econômico·CL · BR · UY·3 days ago
HealthNotableConfirmedDeveloping
10.0
Merck secures voluntary licensing for experimental HIV prevention drug in developing nations
STAT NewsLO·US·2 days ago